Medindia LOGIN REGISTER
Medindia
CRISPR Gene Editing can Treat Diseases Before Birth
Advertisement

CRISPR Gene Editing can Treat Diseases Before Birth

Author -  Dr. Namitha Kumar, MA, PhD
Medically Reviewed by 
The Medindia Medical Review Team on October 9, 2018 at 6:04 PM
Highlights:
  • CRISPR-Cas9 has been hailed as the gene editing tool of choice to correct genetic disorders
  • For the first time, scientists have used CRISPR-Cas9 guided gene editing to prevent genetic disorders before birth
  • An effective tool was used for prenatal gene editing to edit out disease-causing genes in the fetus
  • CRISPR-Cas9 and base editor 3 (BE3) gene-editing tools were used to reduce cholesterol levels, improve liver function and prevent neonatal death

CRISPR-Cas9 has been hailed as the gene editing tool of choice to correct genetic disorders. For the first time, scientists have used CRISPR-Cas9 guided gene editing to prevent genetic disorders before birth.

The Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have demonstrated an effective tool which can be used for prenatal gene editing to edit out disease-causing genes in the fetus. Using mouse models, the team used CRISPR-Cas9 and base editor 3 (BE3) gene-editing tools the researchers reduced cholesterol levels, improved liver function and prevented neonatal death in mice affected by a deadly mutation causing the disease hereditary tyrosinemia type 1 (HT1).

Listen to this article
0:00/0:00
Advertisement


Hereditary tyrosinemia type 1 (HT1) is a genetic disorder leading to increased blood levels of amino acid tyrosine which is a building block of proteins. This disorder is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase which is essential to break down tyrosine. The enzyme deficiency is due to a genetic mutation in the FAH gene.

The disease appears in infancy and presents with symptoms like jaundice, vomiting, diarrhea, nosebleeds and general weakness. HT1 can often lead to total liver and kidney failure.
Advertisement

Treatment with nitisinone must be started at the earliest along with a strict diet with restricted tyrosine and phenylalanine.

The proof-of-concept demonstrated by the research group is a precursor to the potential for CRISPR-Cas9 guided gene editing to cure genetic disorders before birth. According to the study co-leader William H. Peranteau, MD, pediatric and fetal surgeon at CHOP's Center for Fetal Diagnosis and Treatment, the team hopes to use this strategy for prenatal interventions to cure hereditary diseases which have no treatment and potentially fatal.

Kiran Musunuru, MD, PhD, MPH, associate professor of cardiovascular medicine at Penn and study co-leader said that the group used base editing to turn off the disease-causing genetic mutation.

In the current study, the researchers used base editor 3 which is safer than just using CRISPR-Cas9. The mice which were treated with BE3 had improved liver function and better survival rates than mice which were just administered with nitisinone.

To deliver BE3, the group used adenoviruses which are proven to be effective in gene therapeutics. The group is also looking at other delivery mechanisms like lipid nanoparticles to avoid unintended side effects of adenoviruses.

Future directions include further investigations into base editing to move beyond genetic diseases associated with just the liver. According to Peranteau, more time is needed to translate this into bedside clinical applications. However, this mode of gene editing has immense potential for life-threatening genetic disorders.

The study has been published in Nature Medicine.

References:
  1. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice - (https://www.nature.com/articles/s41591-018-0209-1)
  2. Tyrosinemia type 1- (https://rarediseases.info.nih.gov/diseases/2658/tyrosinemia-type-1)


Source: Medindia
Font : A-A+

Cite this Article   close

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Health In Focus

The Eggstraordinary Superfood: Health Secrets of Eggs
Unraveling the nutritional might of eggs! Dive deep into the science-backed benefits of this superfood and its role in holistic well-being.
Favipiravir in Kids With COVID Causes Eye Color Change as a Side Effect
A recent report, highlighted a rare side-effect of COVID medication in children. Read more to find out.
Katalin Karikó and Drew Weissman Receive the Nobel Prize in Physiology or Medicine
Karikó and Weissman's mRNA breakthroughs spark a vaccine revolution, saving millions in the COVID-19 crisis.
Sugar Tax: An Innovative Health Initiative To Curb Diabetes
Is tax on sugar containing beverages an effective initiative to fight Diabetes? Read more to find out.
TB Drug Shortage in India: Can India Achieve Its Goal of Eradicating TB by 2025
Explore the dire TB drug shortage crisis in India, its consequences, and the urgent need for solutions to save lives.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

CRISPR Gene Editing can Treat Diseases Before Birth Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests